Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gattermann

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Leukemia|January 1, 1992
Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring systemC Aul, N Gattermann, A Heyll, et al.
Leukemia|February 13, 2002
Thalidomide for the treatment of patients with myelodysplastic syndromesC Strupp, U Germing, M Aivado, et al.
Annals of Hematology|July 28, 2001
Hemoglobinopathy York [beta146 (HC3) His==>Pro]: first report of a family historyE Misgeld, N Gattermann, A Wehmeier, et al.
Leukemia & Lymphoma|June 20, 2007
A pilot study of bendamustine in elderly patients with high-risk MDS and AMLC Strupp, S Knipp, J Hartmann, et al.
Annals of Hematology|October 10, 2002
Vertebral fractures in multiple myeloma: first results of assessment of fracture risk using dynamic contrast-enhanced magnetic resonance imagingA Scherer, H-J Wittsack, C Strupp, et al.
Leukemia Research|March 1, 1997
Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemiaC Aul, N Gattermann, U Germing, et al.
Neurology|December 30, 2004
CIDP and isolated osteosclerotic myelomaJ Nickel, E Neuen-Jacob, A Saleh, et al.
European Journal of Haematology|February 14, 2004
Thalidomide for the treatment of idiopathic myelofibrosisC Strupp, U Germing, A Scherer, et al.
Cancer|January 15, 1994
Serum deoxythymidine kinase in myelodysplastic syndromesC Aul, N Gattermann, U Germing, et al.
Leukemia|December 5, 2008
Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapyD Bruennert, A Czibere, I Bruns, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Leukemia|January 1, 1992
Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring systemC Aul, N Gattermann, A Heyll, et al.
Leukemia|February 13, 2002
Thalidomide for the treatment of patients with myelodysplastic syndromesC Strupp, U Germing, M Aivado, et al.
Annals of Hematology|July 28, 2001
Hemoglobinopathy York [beta146 (HC3) His==>Pro]: first report of a family historyE Misgeld, N Gattermann, A Wehmeier, et al.
Leukemia & Lymphoma|June 20, 2007
A pilot study of bendamustine in elderly patients with high-risk MDS and AMLC Strupp, S Knipp, J Hartmann, et al.
Annals of Hematology|October 10, 2002
Vertebral fractures in multiple myeloma: first results of assessment of fracture risk using dynamic contrast-enhanced magnetic resonance imagingA Scherer, H-J Wittsack, C Strupp, et al.
Leukemia Research|March 1, 1997
Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemiaC Aul, N Gattermann, U Germing, et al.
Neurology|December 30, 2004
CIDP and isolated osteosclerotic myelomaJ Nickel, E Neuen-Jacob, A Saleh, et al.
European Journal of Haematology|February 14, 2004
Thalidomide for the treatment of idiopathic myelofibrosisC Strupp, U Germing, A Scherer, et al.
Cancer|January 15, 1994
Serum deoxythymidine kinase in myelodysplastic syndromesC Aul, N Gattermann, U Germing, et al.
Leukemia|December 5, 2008
Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapyD Bruennert, A Czibere, I Bruns, et al.
Pageof 11